In vivo proton range verification: a review

被引:412
作者
Knopf, Antje-Christin [1 ]
Lomax, Antony [1 ]
机构
[1] Paul Scherrer Inst, Ctr Proton Therapy, Villigen, Switzerland
关键词
POSITRON-EMISSION-TOMOGRAPHY; BEAM PET MEASUREMENTS; SCATTERING COMPTON CAMERA; MONTE-CARLO SIMULATIONS; PROMPT-GAMMA; RADIATION-THERAPY; BONE-MARROW; RADIOTHERAPY TREATMENT; IMPLANTABLE DOSIMETER; FILTERING APPROACH;
D O I
10.1088/0031-9155/58/15/R131
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Protons are an interesting modality for radiotherapy because of their well defined range and favourable depth dose characteristics. On the other hand, these same characteristics lead to added uncertainties in their delivery. This is particularly the case at the distal end of proton dose distributions, where the dose gradient can be extremely steep. In practice however, this gradient is rarely used to spare critical normal tissues due to such worries about its exact position in the patient. Reasons for this uncertainty are inaccuracies and non-uniqueness of the calibration from CT Hounsfield units to proton stopping powers, imaging artefacts (e. g. due to metal implants) and anatomical changes of the patient during treatment. In order to improve the precision of proton therapy therefore, it would be extremely desirable to verify proton range in vivo, either prior to, during, or after therapy. In this review, we describe and compare state-of-the art in vivo proton range verification methods currently being proposed, developed or clinically implemented.
引用
收藏
页码:131 / 160
页数:30
相关论文
共 178 条
  • [1] Abrosimov N. K., 2006, Journal of Physics: Conference Series, V41, P424, DOI 10.1088/1742-6596/41/1/047
  • [2] Is it necessary to plan with safety margins for actively scanned proton therapy?
    Albertini, F.
    Hug, E. B.
    Lomax, A. J.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2011, 56 (14) : 4399 - 4413
  • [3] The influence of the optimization starting conditions on the robustness of intensity-modulated proton therapy plans
    Albertini, F.
    Hug, E. B.
    Lomax, A. J.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2010, 55 (10) : 2863 - 2878
  • [4] Sensitivity of intensity modulated proton therapy plans to changes in patient weight
    Albertini, Francesca
    Bolsi, Alessandra
    Lomax, Antony J.
    Rutz, Hans Peter
    Timmerman, Beate
    Goitein, Gudrun
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 86 (02) : 187 - 194
  • [5] Experimental validation of the filtering approach for dose monitoring in proton therapy at low energy
    Attanasi, F.
    Belcari, N.
    Camarda, M.
    Del Guerra, A.
    Moehrs, S.
    Rosso, V.
    Vecchio, S.
    Lanconelli, N.
    Cirrone, G. A. P.
    Di Rosa, F.
    Russo, G.
    [J]. PHYSICA MEDICA, 2008, 24 (02) : 102 - 106
  • [6] Extension and validation of an analytical model for in vivo PET verification of proton therapy-a phantom and clinical study
    Attanasi, F.
    Knopf, A.
    Parodi, K.
    Paganetti, H.
    Bortfeld, T.
    Rosso, V.
    Del Guerra, A.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2011, 56 (16) : 5079 - 5098
  • [7] Comparison of two dedicated 'in beam' PET systems via simultaneous imaging of 12C-induced β+-activity
    Attanasi, F.
    Belcari, N.
    Del Guerra, A.
    Enghardt, W.
    Moehrs, S.
    Parodi, K.
    Rosso, V.
    Vecchio, S.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2009, 54 (02) : N29 - N35
  • [8] Bauer J, 2011, MED PHYS, P44
  • [9] Effect of tissue heterogeneity on an in vivo range verification technique for proton therapy
    Bentefour, El Hassane
    Shikui, Tang
    Prieels, Damien
    Lu, Hsiao-Ming
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2012, 57 (17) : 5473 - 5484
  • [10] BENTON EV, 1973, SCIENCE, V182, P474, DOI 10.1126/science.182.4111.474